PSA

18 registered clinical trials studyying PSA — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	MRI-Assisted Guidance for Non-Essential Tissue Sampling NCT07516223	Shanghai East Hospital	N/A
Recruiting	Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test NCT05629494	Albany Medical College	Phase 4
Unknown	Therapeutic Study of Prostatitis With Elevated PSA NCT05732441	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Unknown	Retrospective Chart Review of Treataprost Added to Antibiotic Treatment in Patients With Chronic Prostatitis NCT05306314	GMG Grand Medical	—
Completed	Smart Prostate Specific Antigen (PSA) Screening Study NCT04782713	University of Illinois at Chicago	N/A
Active Not Recruiting	Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA NCT04319783	Trans Tasman Radiation Oncology Group	Phase 2
Unknown	PSA Glycomics Assay for Early Detection of Prostate Cancer NCT04393376	Prof.dr. H.P. Beerlage	N/A
Active Not Recruiting	Marker Driven Selection of Patients for Prostate Biopsy and Management NCT04240327	University of Miami	—
Enrolling By Invitation	RegisterPROS - a Registry for Prostate Cancers NCT06872619	Wren Laboratories LLC	—
Unknown	Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined Wi NCT04251546	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	—
Completed	Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications NCT04081636	Albany Medical College	N/A
Recruiting	EDRN Prostate MRI Biomarker Study NCT03784924	University of Michigan	—
Active Not Recruiting	MRI Prostate for Chinese Men Being Screened for Prostate Cancer NCT03891732	Chinese University of Hong Kong	—
Unknown	Prostate Impendance Test Project NCT03428087	University of Pisa	—
Completed	Promoting CSD500 Use Among Women in Established Relationships NCT02934620	Ohio State University	N/A
Terminated	Altered PSA Test Due to Possible Suspected Heterophilic Antibodies NCT02455466	University of Zurich	—
Terminated	OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Rece NCT01681433	Costantine Albany	Phase 2
Completed	Closing the Gap in Care in Seronegative Inflammatory Arthritis NCT01749618	Pope Research Corporation	N/A